1. 1/09/2019-31/08/2022 Fundación La Caixa (España y Portugal). Nitric Oxide signaling and proteoglycans in Marfan syndrome’s aortopathy: mechanisms and new therapeutic targets
    2. 01/01/2018-31/12/2021 Comunidad Autónoma de Madrid (CAM; Regional Government). Mediators and molecular mechanisms of aortic and valvular pathologies. B2017/BMD-3676 “AORTASANA-CM” https://aortasana.es/
    3. 01/01/2019-31/12/2021 Ministerio de Ciencia, Innovación y Universidades (MICINN). Nitric Oxide and Adamts Members and Substrates in Marfan syndrome and Familial Thoracic Aortic Aneurysm and Dissection (NOXACAND)
    4. 01/01/2017-31/12/2020 Centro de Investigación Biomédica en Red (CIBER). Role of Angiotensin-II- and Calcineurin-regulated genes in the pathogenesis of Thoracic Aortic Diseases and other pathologies involving vascular wall remodeling